/
IMRX
$5.20+$0.13 (+2.56%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$328.0M
65M shares
52-week range
$2.90 – $10.08
32% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-24.75
Immuneering Corporation Class A Common Stock
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
www.immuneering.com- Employees
- 57
- IPO / List date
- Jul 30, 2021
- HQ
- CAMBRIDGE, MA
Held by traders on TradeandTell
No one on the platform currently holds IMRX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 72,875 | $384.1K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded IMRX yet.
